Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes.
Julio A RamirezThomas R ChandlerStephen P FurmanekRuth CarricoAshley M WildeDaniya SheikhRaghava AmbadapoodiVidyulata SalunkheMohammad TahboubForest W ArnoldJose BordonRodrigo Cavallazzinull nullPublished in: Open forum infectious diseases (2023)
Approximately 1 in 10 hospitalized patients with CAP is immunocompromised, with advanced-stage cancer being the most frequent immunocompromising condition, as seen in half of all patients who are immunocompromised. Risk for hospitalization may be influenced by socioeconomic disparities and/or race. ICHs have a 2-fold increase in mortality as compared with non-ICHs.
Keyphrases
- community acquired pneumonia
- end stage renal disease
- respiratory failure
- chronic kidney disease
- newly diagnosed
- ejection fraction
- risk factors
- papillary thyroid
- prognostic factors
- cardiovascular events
- squamous cell carcinoma
- cardiovascular disease
- insulin resistance
- young adults
- adipose tissue
- intensive care unit
- squamous cell
- extracorporeal membrane oxygenation
- skeletal muscle
- patient reported
- affordable care act